Tang; Hengli

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tang; Hengli.The latest application filed is for "anti-flavivirus compounds and methods of use".

Company Profile

7.13.17

Tang; Hengli - Tallahassee FL
Tang, Hengli - Shaan Ki CN
Tang, Hengli - Carlsbad CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Emetine compounds for treatment and prevention of flavivirus infection Grant 11,207,315 - Tang , et al. December 28, 2	2021-12-28
Anti-flavivirus compounds and methods of use Grant 11,096,927 - Tang , et al. August 24, 2	2021-08-24
Compounds and methods for treatment and prevention of Flavivirus infection Grant 10,940,188 - Tang , et al. March 9, 2	2021-03-09
Anti-flavivirus Compounds And Methods Of Use App 20200289471 - TANG; HENGLI ; et al.	2020-09-17
Anti-flavivirus Compounds And Methods Of Use App 20200197369 - TANG; HENGLI ; et al.	2020-06-25
Compounds And Methods For Treatment And Prevention Of Flavivirus Infection App 20200164051 - TANG; HENGLI ; et al.	2020-05-28
Emetine Compounds For Treatment And Prevention Of Flavivirus Infection App 20200121672 - TANG; HENGLI ; et al.	2020-04-23
Emetine compounds for treatment and prevention of flavivirus infection Grant 10,555,942 - Tang , et al. Feb	2020-02-11
Emetine Compounds For Treatment And Prevention Of Flavivirus Infection App 20190105318 - TANG; Hengli ; et al.	2019-04-11
Compounds And Methods For Treatment And Prevention Of Flavivirus Infection App 20180015153 - TANG; HENGLI ; et al.	2018-01-18
Hepatitis Virus Culture Systems Using Stem Cell-Derived Human Hepatocyte-Like Cells and Their Methods of Use App 20140322704 - Tang; Hengli ; et al.	2014-10-30
RNAi therapeutic for treatment of Hepatitis C infection Grant 8,871,919 - Tang October 28, 2	2014-10-28
RNAi therapeutic for treatment of hepatitis C infection Grant 8,563,529 - Tang October 22, 2	2013-10-22
RNAi therapeutic for treatment of hepatitis C infection Grant 8,466,274 - Tang June 18, 2	2013-06-18
NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION App 20130028964 - TANG; HENGLI	2013-01-31
NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION App 20130028965 - TANG; HENGLI	2013-01-31
NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION App 20120316222 - TANG; HENGLI	2012-12-13
RNAi therapeutic for treatment of hepatitis C infection Grant 8,318,925 - Tang November 27, 2	2012-11-27
RNAi therapeutic for treatment of hepatitis C infection Grant 8,252,763 - Tang August 28, 2	2012-08-28
NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION App 20110152356 - TANG; HENGLI	2011-06-23
NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION App 20110142921 - TANG; HENGLI	2011-06-16
RNAi therapeutic for treatment of hepatitis C infection Grant 7,910,722 - Tang March 22, 2	2011-03-22
Method of indefinite culture of hepatitis C virus Grant 7,759,087 - Tang July 20, 2	2010-07-20
NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION App 20100041733 - TANG; HENGLI	2010-02-18
Intact hepatitis c virus and the method for culturing it in a vitro cell culture App 20040166488 - Tang, Hengli ; et al.	2004-08-26
Compositions and methods for production of RNA viruses and RNA virus-based vector particles App 20030039955 - Feng, Yu ; et al.	2003-02-27

Company Registrations

SEC

0001318923

TANG HENGLI

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.